Telmisartan

Chemical formula: C₃₃H₃₀N₄O₂  Molecular mass: 514.617 g/mol  PubChem compound: 65999

Therapeutic indications

Telmisartan is indicated for:

Essential hypertension

Population group: only adults (18 years old or older)

Treatment of essential hypertension in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cardiovascular prevention

Population group: only adults (18 years old or older)

Reduction of cardiovascular morbidity in adults with:

  • manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or
  • type 2 diabetes mellitus with documented target organ damage.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Telmisartan is contraindicated in the following cases:

Pregnancy

Pregnancy

Biliary obstructive disorders

Obstruction of biliary tree

Severe hepatic impairment

Hepatic failure stage IV

Aliskiren in diabetes mellitus or renal impairment

Aliskiren and additionally at least one of
Diabetes mellitus



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: MICARDIS Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈